Summary

Intranasal Corticosteroids: Global Industry Analysis 2018-2022 and Opportunity Assessment 2023-2033

A recent market study published by FMI on Intranasal Corticosteroids offers a global industry analysis for 2018-2022 and opportunity assessment for 2023-2033. The study offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historical and current growth parameters, the growth prospects of the market are obtained with maximum precision.

Market Segmentation

By Drug:

• Fluticasone Propionate
• Budesonide
• Beclomethasone Dipropionate
• Mometasone Furoate
• Triamcinolone Acetonide
• Ciclesonide
• Flunisolide
• Tixocortol

By Indication:

• Allergic Rhinitis (AR)
• Non-Allergic Rhinitis (NAR)

By Dosage Form:

• Intranasal Drops
• Intranasal Sprays

By Distribution Channel:

• Hospitals Pharmacies
• Drug Stores
• Retail Pharmacies
• Online Pharmacies

By Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• Middle East and Africa


Report Chapters

Executive Summary

The executive summary of the Intranasal Corticosteroids includes the global market outlook, demand side trends, supply side trends and also include FMI analysis and recommendations of Intranasal Corticosteroids.

Chapter 01 - Market Overview

Readers can find the detailed segmentation and definition of the Intranasal Corticosteroids in this chapter, which will help to understand basic information about Intranasal Corticosteroids. This section also highlights the market scope, taxonomy and limitations which help the reader understand the market coverage of Intranasal Corticosteroids report.

Chapter 02 - Market Background

This chapter includes detailed analysis of the By Drug processing methods overview, consumer buying patterns & tendencies and policy developments and regulatory scenario. It also includes in depth analysis of macro-economic factors and covers topics like global GDP growth outlook, global industry value added, personal consumption, expenditures, modern trade penetration and consumer price indices. The chapter also covers forecast factors - relevance & impact, value chain analysis and market dynamics (drivers, restraints and opportunities) to better understand the market.

Chapter 03 - Global Intranasal Corticosteroids Demand Analysis 2018-2022 and Forecast, 2023-2033

The chapter include historical market value (USD 6.5 Billion) analysis (2018-2022) and current and future market value (USD 11.2 Billion) and volume (5.0%) projections (2023-2033). The projections are based on the Y-O-Y growth trend analysis and absolute $ opportunity analysis country of operation.

Chapter 04 - Global Intranasal Corticosteroids - Pricing Analysis

Based on By Drug, the pricing analysis chapter include Regional pricing analysis (USD/MT), global average pricing analysis benchmark, and key factors impacting the pricing.

Chapter 05 - Global Intranasal Corticosteroids Analysis 2018-2022 and Forecast 2023-2033, By Drug

Based on By Drug, Intranasal Corticosteroids is segmented into Fluticasone Propionate, Budesonide, Beclomethasone Dipropionate, Mometasone Furoate, Triamcinolone Acetonide, Ciclesonide, Flunisolide, Tixocortol. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Drug.

Chapter 06 - Global Intranasal Corticosteroids Analysis 2018-2022 and Forecast 2023-2033, By Indication

Based on By Indication, Intranasal Corticosteroids is segmented into Allergic Rhinitis (AR), Non-Allergic Rhinitis (NAR). Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Indication.
Chapter 07 - Global Intranasal Corticosteroids Analysis 2018-2022 and Forecast 2023-2033, By Dosage Form

Based on By Dosage Form, Intranasal Corticosteroids is segmented into Intranasal Drops, Intranasal Sprays. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Dosage Form.


Chapter 08 - Global Intranasal Corticosteroids Analysis 2018-2022 and Forecast 2023-2033, By Distribution Channel

Based on By Distribution Channel, Intranasal Corticosteroids is segmented into Hospitals Pharmacies, Drug Stores, Retail Pharmacies, Online Pharmacies. This section also offers market attractiveness analysis based on By Distribution Channel. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Distribution Channel.

Chapter 09 - Intranasal Corticosteroids Analysis 2018-2022 and Forecast 2023-2033, By Region

Based on By Region, Intranasal Corticosteroids is segmented into North America, Latin America, Europe, East Asia, South Asia, Oceania and MEA. This section also offers market attractiveness analysis based on By Region. Readers can also find value forecast and Y-o-Y growth comparison for all above mentioned By Region.

Chapter 10 - North America Intranasal Corticosteroids Analysis 2018-2022 and Forecast 2023-2033

This chapter includes a detailed analysis of the growth of the Intranasal Corticosteroids in the North American region, along with a country-wise assessment that includes the US and Canada. Readers can also find regional trends, regulations, and market growth based on different segment and countries in the North America region.

Chapter 11 - Latin America Intranasal Corticosteroids Analysis 2018-2022 and Forecast 2023-2033

This chapter includes a detailed analysis of the growth of Intranasal Corticosteroids in the Latin America region, along with a country-wise assessment that includes the Brazil, Mexico, Chile, Argentina, Peru and Rest of Latin America. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Intranasal Corticosteroids in the Latin America region.

Chapter 12 - Europe Intranasal Corticosteroids Analysis 2018-2022 and Forecast 2023-2033

This chapter includes a detailed analysis of the growth of Intranasal Corticosteroids in the European region, along with a country-wise assessment that includes the Germany, Italy, France, U.K., Spain, Russia, Nordic, Benelux and Rest of Europe. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Intranasal Corticosteroids in the regional market.

Chapter 13 - East Asia Intranasal Corticosteroids Analysis 2018-2022 and Forecast 2023-2033

This chapter includes a detailed analysis of the growth of Intranasal Corticosteroids in the East Asia region, along with a country-wise assessment that includes the China, Japan, and South Korea. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Intranasal Corticosteroids in the regional market.

Chapter 14 - South Asia Intranasal Corticosteroids Analysis 2018-2022 and Forecast 2023-2033

This chapter includes a detailed analysis of the growth of Intranasal Corticosteroids in the South Asia region, along with a country-wise assessment that includes the India, Indonesia, Malaysia, Thailand, and Rest of South Asia. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Intranasal Corticosteroids in the regional market.

Chapter 15 - Middle East and Africa Intranasal Corticosteroids Analysis 2018-2022 and Forecast 2023-2033

This chapter includes a detailed analysis of the growth of Intranasal Corticosteroids in the MEA region, along with a country-wise assessment that includes the GCC Countries, South Africa, North Africa, Turkey and Rest of MEA. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Intranasal Corticosteroids in the regional market.

Chapter 16 - Key Countries Intranasal Corticosteroids Analysis 2018-2022 and Forecast 2023-2033

This chapter offers insights into how the Intranasal Corticosteroids is expected to grow in major countries globally.

Chapter 17 - Market Structure Analysis- Global Assessment

This chapter includes company dashboard, industry structure analysis by tier of companies, 2022E, company share analysis of top players, 2022E, and competition benchmarking- matrix.

Chapter 18 - Competition Deep Dive (Tentative List)

This chapter includes company overview, By Drug portfolio of companies, profitability by market segments, sales footprint, SWOT analysis and strategy overview of the companies being studied in the report. Some of the market players featured in the report are Merck & co., GlaxoSmithKline, AstraZeneca, Sanofi, Perrigo Co., Teva Pharmaceutical Industries, Glenmark Pharmaceuticals, Mylan, Novartis, Pfizer, Pharmascience

Chapter 19 - Assumptions and Acronyms

This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the Intranasal Corticosteroids report.

Chapter 20 - Research Methodology

This chapter helps readers understand the research methodology followed to obtain various conclusions, as well as important qualitative and quantitative information, on Intranasal Corticosteroids.

ページTOPに戻る

Table of Contents

1. Executive Summary
2. Market Overview
3. Key Market Trends
4. Value Added Insights
5. Market Background
6. Global Market Demand (in Value or Size in USD Million) Analysis 2017 to 2022 and Forecast, 2023 to 2033
7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Drug
7.1. Fluticasone Propionate
7.2. Budesonide
7.3. Beclomethasone Dipropionate
7.4. Mometasone Furoate
7.5. Triamcinolone Acetonide
7.6. Ciclesonide
7.7. Flunisolide
7.8. Tixocortol
8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Indication
8.1. Allergic Rhinitis (AR)
8.1.1. Seasonal AR
8.1.2. Perennial AR
8.2. Non-Allergic Rhinitis (NAR)
8.2.1. Infectious NAR
8.2.2. Vasomotor NAR
8.2.3. Atrophic NAR
9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Dosage Form
9.1. Intranasal Drops
9.2. Intranasal Sprays
10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Distribution Channel
10.1. Hospitals
10.2. Retail Pharmacies
10.3. Drug Stores
10.4. Online Pharmacies
11. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Region
11.1. North America
11.2. Latin America
11.3. Europe
11.4. East Asia
11.5. South Asia
11.6. Oceania
11.7. Middle East and Africa
12. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033
13. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033
14. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033
15. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033
16. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033
17. Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033
18. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033
19. Market Structure Analysis
20. Competition Analysis
20.1. GlaxoSmithKline
20.2. AstraZeneca
20.3. Sanofi
20.4. Perrigo Co.
20.5. Teva Pharmaceutical Industries
20.6. Glenmark Pharmaceuticals
20.7. Mylan
20.8. Novartis
20.9. Pfizer
20.10. Pharmascience
21. Assumptions and Acronyms Used
22. Research Methodology